F.M. Mottaghy

Altunay, B., Schäfer, L., Morgenroth, A., Peña, Q., Lammers, T., Saar, M., Mottaghy, F. M., & Lütje, S. (2025). Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy. Journal of Nuclear Medicine, 66(10), 1522-1527. https://doi.org/10.2967/jnumed.125.270317

Ocal, O., Zech, C. J., Bali, M. A., Pasquier, D., Mottaghy, F., Einspieler, I., Kartalis, N., Bargellini, I., Iezzi, R., Denecke, T., Kunz, W. G., Gebauer, B., Wege, H., Cannella, R., Oprea-Lager, D. E., Vogel, A., Sangro, B., & Seidensticker, M. (2025). Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025). European Radiology. https://doi.org/10.1007/s00330-025-12045-7

Rosen, J., Werner, J.-M., Ceccon, G. S., Rosen, E. K., Wollring, M. M., Stetter, I., Lohmann, P., Mottaghy, F. M., Marner, L., Law, I., Fink, G. R., Langen, K.-J., & Galldiks, N. (2025). Diagnosis of treatment-related changes in children and adolescents with brain and spinal tumors: a cost-effectiveness analysis using MRI and [18 F]FET PET. European Journal of Nuclear Medicine and Molecular Imaging, 52(12), 4616-4626. https://doi.org/10.1007/s00259-025-07377-x

Kuppers, F., Kassem, M., Yun, S. D., Stoffels, G., Filss, C., Galldiks, N., Mottaghy, F. M., Kooi, M. E., Langen, K.-J., Lohmann, P., & Shah, N. J. (2025). Brain Tumor Characterization Using Multiple MR Parameters From Multi-Contrast EPI With Keyhole (GE-SE EPIK) Including Oxygen Extraction Fraction: A Comparison to O-(2-[18F]Fluoroethyl)-L-Tyrosine (FET) Positron Emission Tomography. Journal of Magnetic Resonance Imaging, 62(3), 721-736. https://doi.org/10.1002/jmri.29795

Langen, K.-J., Galldiks, N., Lohmann, P., & Mottaghy, F. M. (2025). Influence of oral protein intake on [<SUP>18</SUP>F]FET uptake in brain tumours. EJNMMI Research, 15(1), Article 109. https://doi.org/10.1186/s13550-025-01304-9

Gavriilidis, P., Koole, M., Mottaghy, F. M., Jansen, F. P., & Wierts, R. (2025). Clinical evaluation of tissue-dependent and spatially-variant positron range correction for Gallium-68 PET imaging. European Journal of Nuclear Medicine and Molecular Imaging. Advance online publication. https://doi.org/10.1007/s00259-025-07456-z

Lütje, S., Schaefer, L., Altunay, B., Hertel, F., Morgenroth, A., & Mottaghy, F. M. (2025). Advancements in non-invasive visualization of the immune checkpoint TIGIT: a systematic review. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07439-0

Biersack, H. J., Rojas-Fernandez, A., Ting, H.-H., Kramer, V., Juweid, M. E., & Mottaghy, F. M. (2025). The promising potential of camelid nanobodies for nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging, 52(8), 2752-2753. https://doi.org/10.1007/s00259-025-07136-y

Schäfer, L., Altunay, B., Heesch, A., van Nijnatten, T., Vaz, S., Juweid, M. E., & Mottaghy, F. M. (2025). Current Approaches of Nuclear Molecular Imaging in Breast Cancer. Cancers, 17(13), Article 2105. https://doi.org/10.3390/cancers17132105

Juweid, M. E., Al-Qasem, S. F., Khuri, F. R., Gallamini, A., Lohmann, P., Ziellenbach, H.-J., & Mottaghy, F. M. (2025). Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine. Ca-A Cancer Journal for Clinicians, 75(3), 226-242. https://doi.org/10.3322/caac.70007